Literature DB >> 33607971

Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia.

Mingyu Tang1, Dong Wang1, Xing Tong1, Yufen Wu1, Jing Zhang1, Lei Zhang1, Yong Yin2, Qing Cao3.   

Abstract

BACKGROUND: Due to the lack of a sensitive, specific and rapid detection method, aetiological diagnosis of pneumonia caused by Mycoplasma pneumoniae (M. pneumoniae, MP) is a constantly challenging issue. This retrospective study aimed to compare the diagnostic methods for Mycoplasma pneumoniae in children and evaluate their values.
METHODS: From November 2018 to June 2019, 830 children with community-acquired pneumonia were selected from the Department of Respiratory Medicine, Shanghai Children's Medical Center. On the first day of hospitalization, sputum, throat swab and venous blood samples were collected to analyse MP-IgM (particle agglutination, PA), MP-IgM (immune colloidal gold technique, GICT), MP-DNA, MP-RNA (simultaneous amplification and testing, SAT) and MP-DNA (real-time polymerase chain reaction, RT-PCR).
RESULTS: Among these 830 children, RT-PCR showed that the positive rate was 36.6% (304/830), in which the positive rate of macrolide resistance (A2063G mutation) accounted for 86.2% of cases (262/304). Using RT-PCR as the standard, MP-RNA (SAT) had the highest specificity (97.5%), and MP-IgM (PA) had the highest sensitivity (74.0%) and Youden index (53.7%). If MP-RNA (SAT) was combined with MP-IgM (PA), its Kappa value (0.602), sensitivity (84.2%), specificity (78.7%) and Youden index (62.9%) were higher than those of single M. pneumoniae detection.
CONCLUSIONS: Our research indicated that a combination of MP-RNA (SAT) plus MP-IgM (PA) might lead to reliable results as an early diagnostic method for children with clinical manifestations of Mycoplasma pneumoniae pneumonia.

Entities:  

Keywords:  Children; Community-acquired pneumonia; Detection methods; Mycoplasma pneumoniae

Year:  2021        PMID: 33607971      PMCID: PMC7893926          DOI: 10.1186/s12887-021-02523-4

Source DB:  PubMed          Journal:  BMC Pediatr        ISSN: 1471-2431            Impact factor:   2.125


  38 in total

1.  Increased reports of Mycoplasma pneumoniae from laboratories in Scotland in 2010 and 2011 - impact of the epidemic in infants.

Authors:  N J Gadsby; A J Reynolds; J McMenamin; R N Gunson; S McDonagh; P J Molyneaux; D L Yirrell; K E Templeton
Journal:  Euro Surveill       Date:  2012-03-08

2.  Detection of Mycoplasma pneumoniae in children with lower respiratory tract infections.

Authors:  Megha Maheshwari; Surinder Kumar; G R Sethi; P Bhalla
Journal:  Trop Doct       Date:  2010-12-01       Impact factor: 0.731

Review 3.  Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection.

Authors:  Nicola Principi; Susanna Esposito
Journal:  J Antimicrob Chemother       Date:  2012-11-20       Impact factor: 5.790

4.  Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.

Authors:  Mayumi Matsuoka; Mitsuo Narita; Norio Okazaki; Hitomi Ohya; Tsutomu Yamazaki; Kazunobu Ouchi; Isao Suzuki; Tomoaki Andoh; Tsuyoshi Kenri; Yuko Sasaki; Atsuko Horino; Miharu Shintani; Yoshichika Arakawa; Tsuguo Sasaki
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

5.  Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.

Authors:  Fei Zhao; Gang Liu; Jiang Wu; Bin Cao; Xiaoxia Tao; Lihua He; Fanliang Meng; Liang Zhu; Min Lv; Yudong Yin; Jianzhong Zhang
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

Review 6.  PCR versus serology for diagnosing Mycoplasma pneumoniae infection: a systematic review & meta-analysis.

Authors:  Lei Zhang; Zhi-Yong Zong; Yan-Bin Liu; Hui Ye; Xiao-Ju Lv
Journal:  Indian J Med Res       Date:  2011-09       Impact factor: 2.375

Review 7.  Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.

Authors:  Hyeon-Jong Yang; Dae Jin Song; Jung Yeon Shim
Journal:  Korean J Pediatr       Date:  2017-06-22

8.  Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015.

Authors:  Maimuna Carrim; Nicole Wolter; Alvaro J Benitez; Stefano Tempia; Mignon du Plessis; Sibongile Walaza; Fahima Moosa; Maureen H Diaz; Bernard J Wolff; Florette K Treurnicht; Orienka Hellferscee; Halima Dawood; Ebrahim Variava; Cheryl Cohen; Jonas M Winchell; Anne von Gottberg
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

9.  Pooled analysis of nuclear acid sequence-based amplification for rapid diagnosis of Mycoplasma pneumoniae infection.

Authors:  Chong Huang; Pei-Ting Huang; Jie-Ying Yao; Zhong-Wei Li; Luo-Bei Weng; Xu-Guang Guo
Journal:  J Clin Lab Anal       Date:  2019-03-06       Impact factor: 2.352

Review 10.  Mycoplasma pneumoniae: Current Knowledge on Nucleic Acid Amplification Techniques and Serological Diagnostics.

Authors:  Katherine Loens; Margareta Ieven
Journal:  Front Microbiol       Date:  2016-03-31       Impact factor: 5.640

View more
  3 in total

1.  Clinical significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia.

Authors:  Soojeong Choo; Yun Young Lee; Eun Lee
Journal:  BMC Pulm Med       Date:  2022-05-30       Impact factor: 3.320

2.  Effect of COVID-19 on childhood Mycoplasma pneumoniae infection in Chengdu, China.

Authors:  Ying Zhang; Yijie Huang; Tao Ai; Jun Luo; Hanmin Liu
Journal:  BMC Pediatr       Date:  2021-04-28       Impact factor: 2.125

3.  Clinical significance of Mycoplasma pneumoniae specific IgM titer in children hospitalized with Mycoplasma pneumoniae pneumonia.

Authors:  Soojeong Choo; Seo-Hee Kim; Eun Lee
Journal:  BMC Infect Dis       Date:  2022-05-16       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.